Metraipolis › archive › dc_842924afc8fc

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients — Europe PMC PMID:41538179

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41538179
DOI
10.1001/jamanetworkopen.2025.54235
License (as archived)
solo-consultazione
Archived
2026-11-07T02:52:11.240Z
SHA-256 of the archived text
c5709a64bc17215502ac7d2fded94297081c220365bbd5320a7e522cdee2199b
Stable URL of this page
https://metraipolis.com/documento/dc_842924afc8fc

How to cite

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients — Europe PMC PMID:41538179 — Europe PMC (en), https://europepmc.org/article/MED/41538179 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_842924afc8fc (Metraipolis archive dc_842924afc8fc, sha256 c5709a64bc17215502ac7d2fded94297081c220365bbd5320a7e522cdee2199b)
BibTeX
@misc{dc842924afc8fc,
  title = {Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients — Europe PMC PMID:41538179},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41538179},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_842924afc8fc; sha256 c5709a64bc17215502ac7d2fded94297081c220365bbd5320a7e522cdee2199b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41538179. Agents can read the archived copy with the MCP tool read_document.